Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of YZJ-1139 for chronic insomnia
ChiCTR2000040794Phase 2Completed
- Sponsor
- Peking University People's Hospital
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic insomnia and primary insomnia comparing YZJ-1139 group with Placebo group (2 arms). Primary endpoint: Sleep efficiency. Started Apr 2019; status: completed.
02
Drugs
fazamorexant
03
Conditions
chronic insomniaprimary insomnia
Beyond the preview
Go deeper on ChiCTR2000040794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040794.